Tokyo Tape
Sign in
← Medinet

Quarterly report · Q3

2370.TEDINET S100RNR9
Period2022-10-01 → 2023-06-30
Filed2023-08-10
StandardJapan GAAP
ConsolidatedNo
Data checks10 of 10 passed
Key figures · 34
MetricValuePeriodScopeSource row
Revenue¥492m2022-10-01 → 2023-06-30StandaloneNet sales
Revenue¥634m2021-10-01 → 2022-09-30StandaloneNet sales (5-year summary)
Revenue¥470m2021-10-01 → 2022-06-30StandaloneNet sales
Operating income−¥1.0bn2022-10-01 → 2023-06-30StandaloneOperating income
Operating income−¥988m2021-10-01 → 2022-06-30StandaloneOperating income
Ordinary income−¥1.0bn2022-10-01 → 2023-06-30StandaloneOrdinary income
Ordinary income−¥1.3bn2021-10-01 → 2022-09-30StandaloneOrdinary income loss (5-year summary)
Ordinary income−¥984m2021-10-01 → 2022-06-30StandaloneOrdinary income
Profit before tax−¥1.0bn2022-10-01 → 2023-06-30StandaloneIncome before income taxes
Profit before tax−¥985m2021-10-01 → 2022-06-30StandaloneIncome before income taxes
Net income−¥1.0bn2022-10-01 → 2023-06-30StandaloneProfit loss
Net income−¥1.3bn2021-10-01 → 2022-09-30StandaloneNet income loss (5-year summary)
Net income−¥989m2021-10-01 → 2022-06-30StandaloneProfit loss
Total assets¥5.5bnat 2023-06-30StandaloneAssets
Total assets¥6.1bnat 2022-09-30StandaloneAssets
Total assets¥6.3bnat 2022-06-30StandaloneTotal assets (5-year summary)
Total liabilities¥564mat 2023-06-30StandaloneLiabilities
Total liabilities¥566mat 2022-09-30StandaloneLiabilities
Net assets / equity¥5.0bnat 2023-06-30StandaloneNet assets
Net assets / equity¥5.5bnat 2022-09-30StandaloneNet assets
Net assets / equity¥5.7bnat 2022-06-30StandaloneNet assets (5-year summary)
Cash and deposits¥4.1bnat 2023-06-30StandaloneCash and deposits
Cash and deposits¥4.5bnat 2022-09-30StandaloneCash and deposits
EPS (basic)¥-4.92022-10-01 → 2023-06-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-1.72023-04-01 → 2023-06-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-6.332021-10-01 → 2022-09-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-5.112021-10-01 → 2022-06-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-1.52022-04-01 → 2022-06-30dStandaloneBasic earnings loss per share (5-year summary)
Equity ratio89.3%at 2023-06-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio90.7%at 2022-09-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio91.4%at 2022-06-30StandaloneEquity to asset ratio (5-year summary)
Shares issued219,986,757at 2023-06-30StandaloneTotal number of issued shares (5-year summary)
Shares issued211,730,423at 2022-09-30StandaloneTotal number of issued shares (5-year summary)
Shares issued211,730,423at 2022-06-30StandaloneTotal number of issued shares (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 20
SegmentItemPeriodValue
Reconciling Itemsreconcilingsegment profit2022-10-01 → 2023-06-30−¥445m
jpcrp040300-q3r_E05351-000Cellular And Tissue Based Product Businessreportable segmentrevenue2022-10-01 → 2023-06-30¥358,000
jpcrp040300-q3r_E05351-000Cellular And Tissue Based Product Businessreportable segmentrevenue external2022-10-01 → 2023-06-30¥358,000
jpcrp040300-q3r_E05351-000Cellular And Tissue Based Product Businessreportable segmentsegment profit2022-10-01 → 2023-06-30−¥359m
jpcrp040300-q3r_E05351-000Contract Cell Manufacturing Businessreportable segmentrevenue2022-10-01 → 2023-06-30¥492m
jpcrp040300-q3r_E05351-000Contract Cell Manufacturing Businessreportable segmentrevenue external2022-10-01 → 2023-06-30¥492m
jpcrp040300-q3r_E05351-000Contract Cell Manufacturing Businessreportable segmentsegment profit2022-10-01 → 2023-06-30−¥242m
—segment totalrevenue2022-10-01 → 2023-06-30¥492m
—segment totalrevenue external2022-10-01 → 2023-06-30¥492m
—segment totalsegment profit2022-10-01 → 2023-06-30−¥601m
Reconciling Itemsreconcilingsegment profit2021-10-01 → 2022-06-30−¥386m
jpcrp040300-q3r_E05351-000Cellular And Tissue Based Product Businessreportable segmentrevenue2021-10-01 → 2022-06-30¥194,000
jpcrp040300-q3r_E05351-000Cellular And Tissue Based Product Businessreportable segmentrevenue external2021-10-01 → 2022-06-30¥194,000
jpcrp040300-q3r_E05351-000Cellular And Tissue Based Product Businessreportable segmentsegment profit2021-10-01 → 2022-06-30−¥425m
jpcrp040300-q3r_E05351-000Contract Cell Manufacturing Businessreportable segmentrevenue2021-10-01 → 2022-06-30¥470m
jpcrp040300-q3r_E05351-000Contract Cell Manufacturing Businessreportable segmentrevenue external2021-10-01 → 2022-06-30¥470m
jpcrp040300-q3r_E05351-000Contract Cell Manufacturing Businessreportable segmentsegment profit2021-10-01 → 2022-06-30−¥178m
—segment totalrevenue2021-10-01 → 2022-06-30¥470m
—segment totalrevenue external2021-10-01 → 2022-06-30¥470m
—segment totalsegment profit2021-10-01 → 2022-06-30−¥603m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 321
ItemContextValueUnit
Interest income noiCurrentYTDDuration_NonConsolidatedMember5168000JPY
Foreign exchange gains noiPrior1YTDDuration_NonConsolidatedMember－JPY
Foreign exchange gains noiCurrentYTDDuration_NonConsolidatedMember349000JPY
Reversal of allowance for doubtful accounts noiPrior1YTDDuration_NonConsolidatedMember4650000JPY
Reversal of allowance for doubtful accounts noiCurrentYTDDuration_NonConsolidatedMember4650000JPY
Income for cancellation of manufacturing noiPrior1YTDDuration_NonConsolidatedMember7699000JPY
Income for cancellation of manufacturing noiCurrentYTDDuration_NonConsolidatedMember8755000JPY
Other noiPrior1YTDDuration_NonConsolidatedMember1156000JPY
Other noiCurrentYTDDuration_NonConsolidatedMember1112000JPY
Non operating incomePrior1YTDDuration_NonConsolidatedMember18582000JPY
Non operating incomeCurrentYTDDuration_NonConsolidatedMember20035000JPY
Interest expenses noePrior1YTDDuration_NonConsolidatedMember79000JPY
Interest expenses noeCurrentYTDDuration_NonConsolidatedMember45000JPY
Foreign exchange losses noePrior1YTDDuration_NonConsolidatedMember250000JPY
Foreign exchange losses noeCurrentYTDDuration_NonConsolidatedMember－JPY
Loss on investments in partnership noePrior1YTDDuration_NonConsolidatedMember7535000JPY
Loss on investments in partnership noeCurrentYTDDuration_NonConsolidatedMember9979000JPY
Stock issuance cost noePrior1YTDDuration_NonConsolidatedMember6471000JPY
Stock issuance cost noeCurrentYTDDuration_NonConsolidatedMember1501000JPY
Bond issuance cost and warrant cost noePrior1YTDDuration_NonConsolidatedMember－JPY
Bond issuance cost and warrant cost noeCurrentYTDDuration_NonConsolidatedMember5696000JPY
Non operating expensesPrior1YTDDuration_NonConsolidatedMember14336000JPY
Non operating expensesCurrentYTDDuration_NonConsolidatedMember17222000JPY
Ordinary incomePrior1YTDDuration_NonConsolidatedMember-984160000JPY
Ordinary incomeCurrentYTDDuration_NonConsolidatedMember-1043553000JPY
Gain on sales of investment securities eiPrior1YTDDuration_NonConsolidatedMember－JPY
Gain on sales of investment securities eiCurrentYTDDuration_NonConsolidatedMember6448000JPY
Extraordinary incomePrior1YTDDuration_NonConsolidatedMember－JPY
Extraordinary incomeCurrentYTDDuration_NonConsolidatedMember6448000JPY
Loss on retirement of noncurrent assets elPrior1YTDDuration_NonConsolidatedMember－JPY
Loss on retirement of noncurrent assets elCurrentYTDDuration_NonConsolidatedMember4829000JPY
Loss on valuation of investment securities elPrior1YTDDuration_NonConsolidatedMember527000JPY
Loss on valuation of investment securities elCurrentYTDDuration_NonConsolidatedMember－JPY
Extraordinary lossPrior1YTDDuration_NonConsolidatedMember527000JPY
Extraordinary lossCurrentYTDDuration_NonConsolidatedMember4829000JPY
Income before income taxesPrior1YTDDuration_NonConsolidatedMember-984688000JPY
Income before income taxesCurrentYTDDuration_NonConsolidatedMember-1041934000JPY
Income taxes currentPrior1YTDDuration_NonConsolidatedMember4092000JPY
Income taxes currentCurrentYTDDuration_NonConsolidatedMember3157000JPY
Income taxes deferredPrior1YTDDuration_NonConsolidatedMember-38000JPY
Income taxes deferredCurrentYTDDuration_NonConsolidatedMember-39000JPY
Income taxesPrior1YTDDuration_NonConsolidatedMember4054000JPY
Income taxesCurrentYTDDuration_NonConsolidatedMember3118000JPY
Profit lossPrior1YTDDuration_NonConsolidatedMember-988743000JPY
Profit lossCurrentYTDDuration_NonConsolidatedMember-1045052000JPY
Revenues from external customersPrior1YTDDuration_NonConsolidatedMember_jpcrp040300-q3r_E05351-000ContractCellManufacturingBusinessReportableSegmentsMember469590000JPY
Revenues from external customersPrior1YTDDuration_NonConsolidatedMember_jpcrp040300-q3r_E05351-000CellularAndTissueBasedProductBusinessReportableSegmentsMember194000JPY
Revenues from external customersPrior1YTDDuration_NonConsolidatedMember_ReportableSegmentsMember469785000JPY
Revenues from external customersPrior1YTDDuration_NonConsolidatedMember_ReconcilingItemsMember－JPY
Revenues from external customersPrior1YTDDuration_NonConsolidatedMember469785000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 10 of 10 passed
balance sheet identitynon_consolidated 2022-09-30pass rounding
balance sheet identitynon_consolidated 2023-06-30pass
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2022-09-30pass
statement vs summary · net assetsnon_consolidated 2023-06-30pass
statement vs summary · revenuenon_consolidated 2021-10-01/2022-06-30pass
statement vs summary · revenuenon_consolidated 2022-10-01/2023-06-30pass
statement vs summary · total assetsnon_consolidated 2022-09-30pass
statement vs summary · total assetsnon_consolidated 2023-06-30pass